Becton, Dickinson and Company Share Price

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 20/05/2024 BST 5-day change 1st Jan Change
237.1 USD +0.35% Intraday chart for Becton, Dickinson and Company +0.08% -2.75%
Sales 2024 * 20.24B 1,592B Sales 2025 * 21.42B 1,686B Capitalization 68.53B 5,393B
Net income 2024 * 2.11B 166B Net income 2025 * 2.48B 195B EV / Sales 2024 * 4.03 x
Net Debt 2024 * 12.96B 1,020B Net Debt 2025 * 10.62B 836B EV / Sales 2025 * 3.69 x
P/E ratio 2024 *
33 x
P/E ratio 2025 *
29.5 x
Employees 73,000
Yield 2024 *
1.58%
Yield 2025 *
1.62%
Free-Float 77.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.35%
1 week+0.08%
Current month+1.08%
1 month+1.29%
3 months-1.47%
6 months+1.48%
Current year-2.75%
More quotes
1 week
234.58
Extreme 234.58
238.34
1 month
230.00
Extreme 230
243.28
Current year
229.40
Extreme 229.395
249.89
1 year
229.40
Extreme 229.395
287.32
3 years
215.90
Extreme 215.9
287.32
5 years
197.75
Extreme 197.75
287.32
10 years
112.15
Extreme 112.15
287.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 31/12/08
Director of Finance/CFO 52 05/09/21
Chief Tech/Sci/R&D Officer 48 31/12/18
Members of the board TitleAgeSince
Director/Board Member 73 23/09/02
Director/Board Member 73 28/01/13
Director/Board Member 69 25/07/10
More insiders
Date Price Change Volume
20/05/24 237.1 +0.35% 967,074
17/05/24 236.3 -0.14% 1,785,047
16/05/24 236.6 -0.28% 1,291,452
15/05/24 237.3 +0.97% 1,168,003
14/05/24 235 -0.82% 1,049,467

Delayed Quote Nyse, May 20, 2024 at 09:00 pm

More quotes
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
237.1 USD
Average target price
279 USD
Spread / Average Target
+17.66%
Consensus